A detailed history of Welch & Forbes LLC transactions in Haleon PLC stock. As of the latest transaction made, Welch & Forbes LLC holds 648,010 shares of HLN stock, worth $6.29 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
648,010
Previous 648,082 0.01%
Holding current value
$6.29 Million
Previous $5.35 Million 28.06%
% of portfolio
0.09%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$8.32 - $10.7 $599 - $770
-72 Reduced 0.01%
648,010 $6.86 Million
Q1 2024

May 02, 2024

SELL
$8.02 - $8.67 $8,020 - $8,670
-1,000 Reduced 0.15%
648,082 $5.5 Million
Q3 2023

Nov 02, 2023

SELL
$7.85 - $8.94 $4,066 - $4,630
-518 Reduced 0.08%
649,082 $5.41 Million
Q2 2023

Jul 28, 2023

SELL
$8.04 - $9.0 $32 - $36
-4 Reduced -0.0%
649,600 $5.44 Million
Q4 2022

Feb 02, 2023

BUY
$5.96 - $8.06 $3.87 Million - $5.24 Million
649,604 New
649,604 $5.2 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Welch & Forbes LLC Portfolio

Follow Welch & Forbes LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.